Search research articles
Contact Us
Filters
Showing results (1-10 of 205) with videos related to
Page
of 21
Sort By:
Cancer Science
|
September 21, 2006
Personalized peptide vaccines: a new therapeutic modality for cancer
Kyogo Itoh, Akira Yamada
Brain and Nerve = Shinkei Kenkyu No Shinpo
|
March 21, 2007
[Peptide vaccination therapy for malignant glioma]
Ryuya Yamanaka, Kyogo Itoh
Biomedicines
|
April 27, 2024
Exploring the Potential of Humoral Immune Response to Commensal <i>Bifidobacterium</i> as a Biomarker for Human Health, including Both Malignant and Non-Malignant Diseases: A Perspective on Detection Strategies and Future Directions
Kyogo Itoh, Satoko Matsueda
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 19, 2011
[Current status and future perspective of cancer vaccine development]
Tetsuro Sasada, Kyogo Itoh
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
May 3, 2005
[HLA-restricted cancer-specific killer T cells]
Mamoru Harada, Kyogo Itoh
Expert Opinion on Biological Therapy
|
May 5, 2007
Peptide-based immunotherapeutic approaches to glioma: a review
Ryuya Yamanaka, Kyogo Itoh
International Journal of Clinical Oncology
|
September 5, 2003
Target molecules in specific immunotherapy against prostate cancer
Mamoru Harada, Masanori Noguchi, Kyogo Itoh
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
September 20, 2011
[Current status and prospects of cancer vaccine therapy]
Takashi Mine, Yasuhiro Terazaki, Kyogo Itoh
Cancer Immunology, Immunotherapy : CII
|
December 1, 2012
Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine
Masanori Noguchi, Tetsuro Sasada, Kyogo Itoh
Cancer Science
|
February 2, 2018
Antitumor activity of antibody against cytotoxic T lymphocyte epitope peptide of lymphocyte-specific protein tyrosine kinase
Satoko Matsueda, Kyogo Itoh, Shigeki Shichijo
Page
of 21
Search research articles
Search
Showing results (1-10 of 205) with videos related to
Sort By:
Page
of 21
Cancer Science
|
September 21, 2006
Personalized peptide vaccines: a new therapeutic modality for cancer
Kyogo Itoh, Akira Yamada
Brain and Nerve = Shinkei Kenkyu No Shinpo
|
March 21, 2007
[Peptide vaccination therapy for malignant glioma]
Ryuya Yamanaka, Kyogo Itoh
Biomedicines
|
April 27, 2024
Exploring the Potential of Humoral Immune Response to Commensal <i>Bifidobacterium</i> as a Biomarker for Human Health, including Both Malignant and Non-Malignant Diseases: A Perspective on Detection Strategies and Future Directions
Kyogo Itoh, Satoko Matsueda
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 19, 2011
[Current status and future perspective of cancer vaccine development]
Tetsuro Sasada, Kyogo Itoh
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
May 3, 2005
[HLA-restricted cancer-specific killer T cells]
Mamoru Harada, Kyogo Itoh
Expert Opinion on Biological Therapy
|
May 5, 2007
Peptide-based immunotherapeutic approaches to glioma: a review
Ryuya Yamanaka, Kyogo Itoh
International Journal of Clinical Oncology
|
September 5, 2003
Target molecules in specific immunotherapy against prostate cancer
Mamoru Harada, Masanori Noguchi, Kyogo Itoh
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
September 20, 2011
[Current status and prospects of cancer vaccine therapy]
Takashi Mine, Yasuhiro Terazaki, Kyogo Itoh
Cancer Immunology, Immunotherapy : CII
|
December 1, 2012
Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine
Masanori Noguchi, Tetsuro Sasada, Kyogo Itoh
Cancer Science
|
February 2, 2018
Antitumor activity of antibody against cytotoxic T lymphocyte epitope peptide of lymphocyte-specific protein tyrosine kinase
Satoko Matsueda, Kyogo Itoh, Shigeki Shichijo
Page
of 21